Literature DB >> 15767433

Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.

Samita S Andreansky1, John Stambas, Paul G Thomas, Weidong Xie, Richard J Webby, Peter C Doherty.   

Abstract

The extent to which CD8+ T cells specific for other antigens expand to compensate for the mutational loss of the prominent DbNP366 and DbPA224 epitopes has been investigated using H1N1 and H3N2 influenza A viruses modified by reverse genetics. Significantly increased numbers of CD8+ KbPB1(703)+, CD8+ KbNS2(114)+, and CD8+ DbPB1-F2(62)+ T cells were found in the spleen and in the inflammatory population recovered by bronchoalveolar lavage from mice that were first given the -NP-PA H1N1 virus intraperitoneally and then challenged intranasally with the homologous H3N2 virus. The effect was less consistent when this prime-boost protocol was reversed. Also, though the quality of the response measured by cytokine staining showed some evidence of modification when these minor CD8+-T-cell populations were forced to play a more prominent part, the effects were relatively small and no consistent pattern emerged. The magnitude of the enhanced clonal expansion following secondary challenge suggested that the prime-boost with the -NP-PA viruses gave a response overall that was little different in magnitude from that following comparable exposure to the unmanipulated viruses. This was indeed shown to be the case when the total response was measured by ELISPOT analysis with virus-infected cells as stimulators. More surprisingly, the same effect was seen following primary challenge, though individual analysis of the CD8+ KbPB1(703)+, CD8+ KbNS2(114)+, and CD8+ DbPB1-F2(62)+ sets gave no indication of compensatory expansion. A possible explanation is that novel, as yet undetected epitopes emerge following primary exposure to the -NP-PA deletion viruses. These findings have implications for both natural infections and vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767433      PMCID: PMC1061524          DOI: 10.1128/JVI.79.7.4329-4339.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR.

Authors:  M K Slifka; J L Whitton
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 2.  Dendritic cells: controllers of the immune system and a new promise for immunotherapy.

Authors:  Jacques Banchereau; Sophie Paczesny; Patrick Blanco; Lynda Bennett; Virginia Pascual; Joseph Fay; A Karolina Palucka
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

Review 3.  Host cell proteases controlling virus pathogenicity.

Authors:  H D Klenk; W Garten
Journal:  Trends Microbiol       Date:  1994-02       Impact factor: 17.079

4.  Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants.

Authors:  Nikolai V Kaverin; Irina A Rudneva; Natalia A Ilyushina; Natalia L Varich; Aleksandr S Lipatov; Yuri A Smirnov; Elena A Govorkova; Asya K Gitelman; Dmitri K Lvov; Robert G Webster
Journal:  J Gen Virol       Date:  2002-10       Impact factor: 3.891

6.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

7.  Protection and compensation in the influenza virus-specific CD8+ T cell response.

Authors:  Richard J Webby; Samita Andreansky; John Stambas; Jerold E Rehg; Robert G Webster; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

8.  Protection against CTL escape and clinical disease in a murine model of virus persistence.

Authors:  Taeg S Kim; Stanley Perlman
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

Review 9.  Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?

Authors:  Young S Hahn
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

10.  Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections.

Authors:  Sherry R Crowe; Stephen J Turner; Shannon C Miller; Alan D Roberts; Rachel A Rappolo; Peter C Doherty; Kenneth H Ely; David L Woodland
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  32 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion.

Authors:  Nicole L La Gruta; William T Rothwell; Tania Cukalac; Natasha G Swan; Sophie A Valkenburg; Katherine Kedzierska; Paul G Thomas; Peter C Doherty; Stephen J Turner
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 3.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

4.  A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies.

Authors:  Nicole L La Gruta; Katherine Kedzierska; Ken Pang; Richard Webby; Miles Davenport; Weisan Chen; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

5.  A simple mathematical model helps to explain the immunodominance of CD8 T cells in influenza A virus infections.

Authors:  Andreas Handel; Rustom Antia
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

6.  A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen.

Authors:  Michael P Bell; Danielle N Renner; Aaron J Johnson; Kevin D Pavelko
Journal:  Viral Immunol       Date:  2014-07-15       Impact factor: 2.257

7.  Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Authors:  Jennifer N Uram; Chelsea M Black; Emilee Flynn; Lanqing Huang; Todd D Armstrong; Elizabeth M Jaffee
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

8.  Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Authors:  Inge E A Flesch; Wai-Ping Woo; Yang Wang; Vijay Panchanathan; Yik-Chun Wong; Nicole L La Gruta; Tania Cukalac; David C Tscharke
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

9.  Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.

Authors:  Jeanette C Reece; Sheilajen Alcantara; Shayarana Gooneratne; Sinthujan Jegaskanda; Thakshila Amaresena; Caroline S Fernandez; Karen Laurie; Aeron Hurt; Shelby L O'Connor; Max Harris; Janka Petravic; Alexey Martyushev; Andrew Grimm; Miles P Davenport; John Stambas; Robert De Rose; Stephen J Kent
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

10.  No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection.

Authors:  Helen R Fryer; Almut Scherer; Annette Oxenius; Rodney Phillips; Angela R McLean
Journal:  Proc Biol Sci       Date:  2009-09-23       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.